← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2004Last known activity
May 15, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (6)
- NCT06419946CollaboratorPhase 3May 15, 2024
- NCT04694586CollaboratorPhase 2Nov 23, 2020
- NCT01975064CollaboratorPhase 4Nov 1, 2013
- NCT01008644Lead sponsorEarly Phase 1Nov 30, 2009
- NCT01008644Sponsor investigatorEarly Phase 1Nov 30, 2009
- NCT00857402CollaboratorN/AFeb 1, 2004
Details
- Last known activity
- May 15, 2024